High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease
A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD)
This multinational pooled analysis of the DANFLU-2 and GALFLU trials evaluated the effect of high-dose versus standard-dose influenza vaccination on cardiovascular outcomes in patients with atherosclerotic cardiovascular disease, addressing whether enhanced immunogenicity translates to better cardiovascular protection.
Summary
Publication date: Available online 18 February 2026Source: JACC
Join us
Join the Global Primary Care Cardio Network. Membership is free.
Would you like to tell us more about yourself?
Interests
We will send you an email with a link to confirm your registration.